Suppr超能文献

新型冠状病毒肺炎住院患者的临床管理

[Clinical management of hospitalised patients with COVID-19].

作者信息

Jeschke Klaus Nielsen, Reiter Nanna, Hvas Anne-Mette, Rasmussen Bodil Steen, Hansen Ejvind Frausing, Marså Kristoffer, Weinreich Ulla Møller, Pedersen Michael, Helleberg Marie, Winding Robert, Kirk Ole, Dalager-Pedersen Michael

出版信息

Ugeskr Laeger. 2021 Mar 1;183(9).

Abstract

COVID-19 is the infectious disease caused by SARS-CoV-2. This is a review of the current treatment strategies available for patients with COVID-19 during hospital admission. Patients requiring hospitalisation frequently suffer from respiratory failure and may require oxygen therapy. Insufficient response to oxygen may be an indication, that other modalities such as high-flow nasal cannula, continuous positive airway pressure or mechanical ventilation are needed. The only medical treatments currently being used are remdesivir and dexamethasone.

摘要

新型冠状病毒肺炎(COVID-19)是由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的传染病。本文综述了COVID-19患者住院期间可用的当前治疗策略。需要住院治疗的患者经常出现呼吸衰竭,可能需要氧疗。对氧疗反应不足可能表明需要其他治疗方式,如高流量鼻导管吸氧、持续气道正压通气或机械通气。目前正在使用的唯一药物治疗是瑞德西韦和地塞米松。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验